Humacyte (HUMA) Depreciation and Depletion (2020 - 2026)

Humacyte (HUMA) has 7 years of Depreciation and Depletion data on file, last reported at $1.3 million in Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $1.3 million, up 2.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.3 million (up 1.81% YoY), and the FY2025 annual result was $5.3 million, up 4.47% from the prior year.
• Depreciation and Depletion held at $1.3 million in Q1 2026 per HUMA's latest filing, from $1.3 million in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $1.6 million in Q1 2023 and troughed at $1.3 million in Q1 2024.
• A 5-year average of $1.4 million and a median of $1.3 million in 2025 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2024 and 2025: Depreciation and Depletion declined 18.23% in 2024, then grew 4.68% in 2025.
• A 5-year view of Depreciation and Depletion shows it stood at $1.6 million in 2022, then declined by 12.38% to $1.4 million in 2023, then decreased by 5.74% to $1.3 million in 2024, then increased by 4.68% to $1.3 million in 2025, then climbed by 0.07% to $1.3 million in 2026.
• Business Quant data shows HUMA's Depreciation and Depletion at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.3 million in Q3 2025.